Primary carcinoma of the liver: description of a case with ethanolaminuria, a new and obscure metabolic defect.

Primary carcinoma of the liver: description of a case with ethanolaminuria, a new and obscure metabolic defect. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Primary carcinoma of the liver: description of a case with ethanolaminuria, a new and obscure metabolic defect. Abstract Text:

Primary carcinoma of the liver: description of a case with ethanolaminuria, a new and obscure metabolic defect. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Primary carcinoma of the liver: description of a case with ethanolaminuria, a new and obscure metabolic defect. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: British journal of cancer

VOLUME: 7

Page Numbers: 166-80

Journal Abbreviation: Br. J. Cancer

ISSN: 0007-0920

DAY: 3

MONTH: Jun

YEAR: 1953

Primary carcinoma of the liver: description of a case with ethanolaminuria, a new and obscure metabolic defect. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370635

Primary carcinoma of the liver: description of a case with ethanolaminuria, a new and obscure metabolic defect. Keywords Mesh Terms:

KEYWORDS: Urine

MESH TERMS: urine

Chemical & Substance for Abstract: Primary carcinoma of the liver: description of a case with ethanolaminuria, a new and obscure metabolic defect. Information

Substance Name: Amino Alcohols

Registry Number: 0

Grant and Affiliation Information for Primary carcinoma of the liver: description of a case with ethanolaminuria, a new and obscure metabolic defect.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br J Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Primary carcinoma of the liver: description of a case with ethanolaminuria, a new and obscure metabolic defect Related Publications

• "Sunflower cataract" in Wilson's disease.
• A CASE OF SECONDARY CARCINOMATOUS INFILTRATION OF THE PIA-ARACHNOID OF THE BRAIN, PRESENTING EXCLUSIVELY OCULAR SYMPTOMS DURING LIFE: MENINGITIS CARCINOMATOSA.
• A Phase I Study of the Safety of the Nutritional Supplement, Active Hexose Correlated Compound, AHCC, in Healthy Volunteers.
• A longitudinal study of the yield and clinical utility of a specifically designed secondary hypertension investigation protocol.
• Acrodermatitis enteropathica.
• Benign recurrent intrahepatic "obstructive" jaundice.
• Cause of death in Wilson disease.
• Characteristics and outcome of anti-glomerular basement membrane disease: a single-center experience.
• Diagnosis of hysteria.
• Disturbances of aminoacid metabolism following liver injury; a study by means of paper chromatography.
• Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival.
• Foetor hepaticus.
• Francis Martin Rouse Walshe, 1885-1973.
• Glutamic acid in hepatic coma.
• Liver and muscle glycogen in normal subjects, in diabetes mellitus and in acute hepatitis; the effects of intravenous adrenaline.
• Liver and muscle glycogen in normal subjects, in diabetes mellitus and in acute hepatitis; under basal conditions.
• Mesangioproliferative glomerulonephritis with IgM deposition: clinical characteristics and outcome.
• Methyl mercaptan in relation to foetor hepaticus.
• Methyl mercaptan in relation to foetor hepaticus.
• Multiple myeloma and renal failure: one center's experience.
• Norwegian scabies.
• Observations on the symptomatology and pathogenesis of hepatic coma.
• On clinical medicine.
• PENICILLAMINE AND MIXED DISULPHIDE EXCRETION IN WILSON'S DISEASE.
• Primary carcinoma of the liver: description of a case with ethanolaminuria, a new and obscure metabolic defect.
• Renal failure associated with alternative medical therapies.
• The HELLP syndrome, a prospective study.
• The action of chelating agents in Wilson's disease.
• The effect of glutamic acid on the coma of hepatic failure.
• Treatment of Wilson's disease with penicillamine.